DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Thirumalai Chemicals Limited — Updates

NSE 2 hrs ago·30 Aug 2026, 6:27 pm

Thirumalai Chemicals

Thirumalai Chemicals Limited has informed the stock exchange that its Board of Directors met on August 30, 2026, to discuss a fund-raising proposal. The company has not yet disclosed the specific details of this plan, such as the amount or the method of raising capital. This move comes as the company seeks to strengthen its financial position and support its future growth initiatives.

For investors, this update is significant as it signals the company's intent to bolster its balance sheet. Depending on the nature of the fund-raising, it could be used for debt repayment, expansion, or working capital. Traders will be closely watching for further announcements to understand the strategic rationale behind the move and its potential impact on the company's financial health.